Results 121 to 130 of about 295,397 (306)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be

open access: yesFrontiers in Immunology, 2019
This study aims to understand what lupus nephritis is, its origin, clinical context, and its pathogenesis. Truly, we encounter many conceptual and immanent tribulations in our attempts to search for the pathogenesis of this disease—and how to explain its
O. Rekvig
semanticscholar   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab

open access: yesArthritis &Rheumatology, EarlyView.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo   +15 more
wiley   +1 more source

Successful Management Strategies for Lupus Nephritis in the Intensive Care Unit: A Case Series

open access: yesArchives of Anesthesia and Critical Care
Lupus nephritis, a severe complication of systemic lupus erythematosus (SLE), often leads to significant renal impairment requiring intensive care. The management of lupus nephritis in the intensive care unit of Dr.
Achmad Marwan   +2 more
doaj   +1 more source

Lupus nephritis: a modern treatment paradigm

open access: yesPočki, 2018
Lupus nephritis is the most common and life-threate­ning manifestation of systemic lupus erythematosus (SLE) and continues to cause a high percentage of terminal renal failure.
I.Yu. Golovach
doaj   +1 more source

Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis [PDF]

open access: yes, 2017
Background. In systemic lupus erythematosus patients, a strong association between the occurrence of antibodies against complement C1q (anti-C1q) and lupus nephritis can be observed.
Bigler, Cornelia   +5 more
core  

Podocyte Injury in Lupus Nephritis

open access: yesJournal of Clinical Medicine, 2019
Systemic lupus erythematosus (SLE) is characterized by a broad spectrum of renal lesions. In lupus glomerulonephritis, histological classifications are based on immune-complex (IC) deposits and hypercellularity lesions (mesangial and/or endocapillary) in
H. Sakhi   +7 more
semanticscholar   +1 more source

Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?

open access: yesArthritis &Rheumatology, EarlyView.
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin   +11 more
wiley   +1 more source

The Clinicopathological Study of Lupus Nephritis

open access: yesÇukurova Üniversitesi Tıp Fakültesi Dergisi, 2014
Purpose: Lupus nephritis is one of the most serious manifestations of Systemic lupus erythematosis and it is a major cause of morbidity and mortality. The aim of this study is to compare males and females in lupus nephritis presentations.
Raouf Rahim Merza   +2 more
doaj  

An Unusual Initial Presentation of Lupus Nephritis as a Renal Mass

open access: yesCase Reports in Nephrology, 2015
Lupus nephritis is a frequent manifestation of systemic lupus erythematous. Lupus nephritis usually presents with abnormal urinalysis, proteinuria, and/or renal insufficiency.
Remi Goupil   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy